• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群,理解中药的新前沿。

Gut microbiota, a new frontier to understand traditional Chinese medicines.

机构信息

School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China; Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Pharmacol Res. 2019 Apr;142:176-191. doi: 10.1016/j.phrs.2019.02.024. Epub 2019 Feb 25.

DOI:10.1016/j.phrs.2019.02.024
PMID:30818043
Abstract

As an important component of complementary and alternative medicines, traditional Chinese medicines (TCM) are gaining more and more attentions around the world because of the powerful therapeutic effects and less side effects. However, there are still some doubts about TCM because of the questionable TCM theories and unclear biological active compounds. In recent years, gut microbiota has emerged as an important frontier to understand the development and progress of diseases. Together with this trend, an increasing number of studies have indicated that drug molecules can interact with gut microbiota after oral administration. In this context, more and more studies pertaining to TCM have paid attention to gut microbiota and have yield rich information for understanding TCM. After oral administration, TCM can interact with gut microbiota: (1) TCM can modulate the composition of gut microbiota; (2) TCM can modulate the metabolism of gut microbiota; (3) gut microbiota can transform TCM compounds. During the interactions, two types of metabolites can be produced: gut microbiota metabolites (of food and host origin) and gut microbiota transformed TCM compounds. In this review, we summarized the interactions between TCM and gut microbiota, and the pharmacological effects and features of metabolites produced during interactions between TCM and gut microbiota. Then, focusing on gut microbiota and metabolites, we summarized the aspects in which gut microbiota has facilitated our understanding of TCM. At the end of this review, the outlooks for further research of TCM and gut microbiota were also discussed.

摘要

作为补充和替代医学的重要组成部分,由于其强大的治疗效果和较少的副作用,中药(TCM)在世界范围内越来越受到关注。然而,由于中医理论的可疑性和生物活性化合物的不明确性,人们对中医仍然存在一些怀疑。近年来,肠道微生物群已成为了解疾病发展和进展的一个重要前沿领域。随着这一趋势,越来越多的研究表明,药物分子在口服后可以与肠道微生物群相互作用。在这种情况下,越来越多的与 TCM 相关的研究开始关注肠道微生物群,并为了解 TCM 提供了丰富的信息。口服 TCM 后可以与肠道微生物群相互作用:(1)TCM 可以调节肠道微生物群的组成;(2)TCM 可以调节肠道微生物群的代谢;(3)肠道微生物群可以转化 TCM 化合物。在相互作用过程中,会产生两种类型的代谢物:肠道微生物群代谢物(食物和宿主来源)和肠道微生物群转化的 TCM 化合物。在这篇综述中,我们总结了 TCM 与肠道微生物群之间的相互作用,以及 TCM 与肠道微生物群相互作用过程中产生的代谢物的药理学作用和特征。然后,我们重点关注肠道微生物群和代谢物,总结了肠道微生物群有助于我们理解 TCM 的方面。在这篇综述的最后,还讨论了进一步研究 TCM 和肠道微生物群的展望。

相似文献

1
Gut microbiota, a new frontier to understand traditional Chinese medicines.肠道微生物群,理解中药的新前沿。
Pharmacol Res. 2019 Apr;142:176-191. doi: 10.1016/j.phrs.2019.02.024. Epub 2019 Feb 25.
2
Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?肠道微生物群能否解决传统草药口服生物利用度的难题?
J Ethnopharmacol. 2016 Feb 17;179:253-64. doi: 10.1016/j.jep.2015.12.031. Epub 2015 Dec 23.
3
Gut microbiota in phytopharmacology: A comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions.植物药理学中的肠道微生物群:概念、相互作用、生物转化和作用模式的全面概述。
Pharmacol Res. 2019 Sep;147:104367. doi: 10.1016/j.phrs.2019.104367. Epub 2019 Jul 22.
4
Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism.中药调节肠道微生物群代谢物介导的脂质代谢机制。
J Ethnopharmacol. 2021 Oct 5;278:114207. doi: 10.1016/j.jep.2021.114207. Epub 2021 May 14.
5
Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.用于治疗骨质疏松症的中药方剂:对抗骨质疏松药物发现的启示。
J Ethnopharmacol. 2016 Aug 2;189:61-80. doi: 10.1016/j.jep.2016.05.025. Epub 2016 May 11.
6
Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach.肠道微生物群调节与中药:一种基于系统生物学的方法。
Pharmacol Res. 2019 Oct;148:104453. doi: 10.1016/j.phrs.2019.104453. Epub 2019 Sep 18.
7
Gut microbiota mediates the pharmacokinetics of Zhi-zi-chi decoction for the personalized treatment of depression.肠道微生物群介导栀子豉汤的药代动力学以实现抑郁症的个性化治疗。
J Ethnopharmacol. 2023 Feb 10;302(Pt B):115934. doi: 10.1016/j.jep.2022.115934. Epub 2022 Nov 19.
8
Autophagy modulators from traditional Chinese medicine: Mechanisms and therapeutic potentials for cancer and neurodegenerative diseases.来自中药的自噬调节剂:癌症和神经退行性疾病的作用机制及治疗潜力
J Ethnopharmacol. 2016 Dec 24;194:861-876. doi: 10.1016/j.jep.2016.10.069. Epub 2016 Oct 26.
9
Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy.中医药的代谢重编程及其在癌症有效治疗中的作用。
Pharmacol Res. 2021 Aug;170:105728. doi: 10.1016/j.phrs.2021.105728. Epub 2021 Jun 11.
10
Repairing gut barrier by traditional Chinese medicine: roles of gut microbiota.中药修复肠道屏障:肠道微生物群的作用。
Front Cell Infect Microbiol. 2024 Jul 4;14:1389925. doi: 10.3389/fcimb.2024.1389925. eCollection 2024.

引用本文的文献

1
The effects of Songling Xuemaikang capsule on vascular remodeling of stage 1 hypertension: a multicenter, randomized placebo-controlled trial protocol.松龄血脉康胶囊对1级高血压血管重塑的影响:一项多中心、随机、安慰剂对照试验方案
BMC Complement Med Ther. 2025 Aug 6;25(1):300. doi: 10.1186/s12906-025-05038-y.
2
The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort.糖尿病肾病中肠道微生物群的变化:来自三重比较队列的见解
Front Cell Infect Microbiol. 2025 Jun 27;15:1606700. doi: 10.3389/fcimb.2025.1606700. eCollection 2025.
3
Efficient utilization of Shuanghuanglian medicine residues by microbial transformation with flavonoid glycosides-hydrolyzing strains.
利用黄酮苷水解菌株通过微生物转化高效利用双黄连药渣。
Front Microbiol. 2025 May 27;16:1553399. doi: 10.3389/fmicb.2025.1553399. eCollection 2025.
4
Mechanistic Study on the Alleviation of Endometritis in Mice Through Inhibition of NF-κB and MAPK Signaling Pathways by Berberine and Carvacrol.黄连素和香芹酚通过抑制NF-κB和MAPK信号通路减轻小鼠子宫内膜炎的机制研究
Microorganisms. 2025 Apr 30;13(5):1051. doi: 10.3390/microorganisms13051051.
5
Qing-Re-Hua-Shi Decoction ameliorates DSS-induced colitis by modulating multiple signaling pathways and remodeling the gut microbiota and metabolite profile.清热化湿汤通过调节多种信号通路以及重塑肠道微生物群和代谢物谱来改善右旋糖酐硫酸钠诱导的结肠炎。
Front Cell Infect Microbiol. 2025 Apr 2;15:1541289. doi: 10.3389/fcimb.2025.1541289. eCollection 2025.
6
Flavonoids regulating NLRP3 inflammasome: a promising approach in alleviating diabetic peripheral neuropathy.黄酮类化合物调节NLRP3炎性小体:缓解糖尿病周围神经病变的一种有前景的方法。
Inflammopharmacology. 2025 Apr 9. doi: 10.1007/s10787-025-01729-7.
7
Jieduquyuziyin prescription attenuates the side effect of prednisone through regulating gut microbiota when in the combination with prednisone treat MRL/lpr mice.解毒祛瘀滋阴方与泼尼松联合治疗MRL/lpr小鼠时,通过调节肠道微生物群减轻泼尼松的副作用。
J Tradit Complement Med. 2024 May 24;15(2):119-127. doi: 10.1016/j.jtcme.2024.05.005. eCollection 2025 Mar.
8
Chaihushugan powder regulates the gut microbiota to alleviate mitochondrial oxidative stress in the gastric tissues of rats with functional dyspepsia.柴胡疏肝散通过调节肠道微生物群来减轻功能性消化不良大鼠胃组织中的线粒体氧化应激。
Front Immunol. 2025 Feb 18;16:1549554. doi: 10.3389/fimmu.2025.1549554. eCollection 2025.
9
Uterine Microbiota and Bisphenols: Novel Influencers in Reproductive Health.子宫微生物群与双酚类物质:生殖健康中的新型影响因素
J Xenobiot. 2025 Feb 2;15(1):26. doi: 10.3390/jox15010026.
10
Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis.黄芩苷:一种治疗急性肾损伤和肾纤维化的潜在药物。
Front Pharmacol. 2025 Jan 22;16:1511083. doi: 10.3389/fphar.2025.1511083. eCollection 2025.